Literature DB >> 9677115

Lymphatic mapping with isosulfan blue dye in squamous cell carcinoma of the head and neck.

K T Pitman1, J T Johnson, H Edington, E L Barnes, R Day, R L Wagner, E N Myers.   

Abstract

OBJECTIVE: To determine whether intraoperative lymphatic mapping with isosulfan blue dye and sentinel lymph node biopsy accurately demonstrates the pathway of regional metastases from mucosal sites in squamous cell carcinoma of the head and neck.
DESIGN: A prospective clinical study of intraoperative lymphatic mapping.
SETTING: An academic tertiary referral center. PATIENTS: Patients with previously untreated squamous cell carcinoma of the head and neck whose surgical treatment included neck dissection. INTERVENTION: Injection of isosulfan blue dye into the mucosa surrounding squamous cell carcinomas of the upper aerodigestive tract during cervical lymphadenectomy. OUTCOME MEASURES: Correlation of the pathologic findings in the blue sentinel lymph node with those in the remaining cervical lymphatics.
RESULTS: No blue-stained cervical lymphatics were identified after injection of the mucosa surrounding the primary squamous cell carcinoma with isosulfan dye.
CONCLUSION: The technique of intraoperative lymphatic mapping with isosulfan blue dye requires further study before it can be used for the detection of occult cervical metastases in squamous cell carcinoma of the head and neck.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9677115     DOI: 10.1001/archotol.124.7.790

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  9 in total

1.  Is there a role for lymphoscintigraphy and sentinel node biopsy in the management of the regional lymphatics in mucosal squamous cell carcinoma of the head and neck?

Authors:  Nicholas Hyde; Elizabeth Prvulovich
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-03-27       Impact factor: 9.236

2.  Follow-up after intraoperative sentinel node biopsy of N0 neck oral cancer patients.

Authors:  Akihiro Terada; Yasuhisa Hasegawa; Yasushi Yatabe; Nobuhiro Hanai; Taijiro Ozawa; Hitoshi Hirakawa; Takashi Maruo; Daisuke Kawakita; Shinji Mikami; Atsushi Suzuki; Takuya Miyazaki; Tsutomu Nakashima
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-08-20       Impact factor: 2.503

Review 3.  Role of sentinel node biopsy in the management and staging of the N0 neck.

Authors:  Gary L Ross; Taimur Shoaib
Journal:  Odontology       Date:  2005-09       Impact factor: 2.634

4.  Sentinel lymph node localization using 1 % isosulfan blue dye in cases of early oral cavity and oropharyngeal squamous cell carcinoma.

Authors:  Purnima Sangwan; Ajith Nilakantan; Uma Patnaik; Awadhesh Mishra; Ashwani Sethi
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2014-08-02

Review 5.  Oral cavity squamous cell carcinoma and the clinically n0 neck: the past, present, and future of sentinel lymph node biopsy.

Authors:  Andrew Coughlin; Vicente A Resto
Journal:  Curr Oncol Rep       Date:  2010-03       Impact factor: 5.075

6.  The first and second echelon sentinel lymph node evaluation in oral cancer.

Authors:  Kuldeep Kumar Bassi; Anurag Srivastava; Vuthaluru Seenu; Rakesh Kumar; Rajinder Parshad; Sunil Chumber; Siddarth Datta Gupta; Sudhir Bahadur
Journal:  Indian J Surg       Date:  2012-06-02       Impact factor: 0.656

Review 7.  Sentinel node biopsy for early oral and oropharyngeal squamous cell carcinoma.

Authors:  Sandro J Stoeckli; Lee W T Alkureishi; Gary L Ross
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-03-21       Impact factor: 2.503

8.  Sentinel node detection in N0 cancer of the pharynx and larynx.

Authors:  J A Werner; A-A Dünne; A Ramaswamy; B J Folz; B M Lippert; R Moll; Th Behr
Journal:  Br J Cancer       Date:  2002-09-23       Impact factor: 7.640

9.  Sentinel lymph-node biopsy in head and neck cancer.

Authors:  S Höft; S Maune; C Muhle; W Brenner; N Czech; W-U Kampen; U Jänig; M Laudien; S Gottschlich; P Ambrosch
Journal:  Br J Cancer       Date:  2004-07-05       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.